A project to develop Perfusio, a proprietary drug delivery system (DDS) that uses a catheter to deliver and retrieve nucleic acid therapeutics from target organs, with the aim of shortening clinical trial timelines and reducing costs and launching sales during fiscal 2027. The project is advancing the establishment of a commercialization and manufacturing and marketing framework through partner selection and consultations with PMDA (the Pharmaceuticals and Medical Devices Agency).